Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients. - Test2 - elhamkhani - TriplyDB

Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients.

Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients.

http://www.wikidata.org/entity/Q37203919

about

Diffuse large B cell gastric lymphoma a rare disease: the effort to obtain scientific data in a multicenter, multinational retrospective trial

P2860

Q31121542-43215AE7-F862-4301-B9C9-E51817FA1A69

P2860

Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients.

http://www.wikidata.org/entity/Q37203919

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Age-adjusted international pro ...... non-Hodgkin lymphoma patients.

@en

Age-adjusted international pro ...... non-Hodgkin lymphoma patients.

@nl

type

label

Age-adjusted international pro ...... non-Hodgkin lymphoma patients.

@en

Age-adjusted international pro ...... non-Hodgkin lymphoma patients.

@nl

prefLabel

Age-adjusted international pro ...... non-Hodgkin lymphoma patients.

@en

Age-adjusted international pro ...... non-Hodgkin lymphoma patients.

@nl

P1433

Q37203919-81613B61-5261-48B3-81C9-B27267B2A5F2

P1476

Q37203919-B3B76C76-00F9-4F7F-9CF9-4172170F5220

P2093

Q37203919-1CFDEEB4-9C7D-4B5C-90D1-A16BB148AF1E

Q37203919-249B4E78-D09E-412C-BBDB-24F1924C87AF

Q37203919-2A2F7338-D068-455D-86B7-26EAE0501EC4

Q37203919-916918FD-3D29-4454-8B6A-B95486CB40FA

Q37203919-9F77D8E5-46D2-493C-BD9A-C4853CB892C1

Q37203919-D1DCD610-B0A8-4A17-AF8E-1C2F446190C4

Q37203919-D344180E-6A25-4E12-A1F2-6568BF1D1C77

P2860

Q37203919-1B1884B4-30B5-47BA-BF6B-7AC93530A944

Q37203919-20742AC9-662E-44D5-9058-B902CAADF1AA

Q37203919-294B922D-E3BD-4EAA-8A8C-F144491AC94D

Q37203919-377F8F91-4562-4D97-A583-CCA8E6A6AAA2

Q37203919-474B7E6A-6971-433C-9D10-B9A990242257

Q37203919-543BF9E4-A7B8-48A8-BC9F-8D4E4C93B052

Q37203919-55461282-29CE-4C0F-9F63-72DE2D3C08A7

Q37203919-5CBEBB96-8CD9-4B3E-A5E8-CD86C70CFE2C

Q37203919-64CAD99E-D35D-4EE8-AE6B-984BF4E1EFE2

Q37203919-B54E0CFE-D29A-4CF1-ADDB-5460D611C26D

P304

Q37203919-6854080F-188F-4F6B-BADC-D485E66161A0

P31

Q37203919-63F9B25F-EDF8-4817-BB2F-97C9BE19F4E5

P356

Q37203919-BA6D4BAF-BC2E-45DE-BF6A-743DDF264EBE

P433

Q37203919-DA2E9208-DBC5-4EF8-8903-332554DB2163

P478

Q37203919-075FE8C0-A6A9-49D7-993D-5A36D113A124

P50

Q37203919-24897D7D-DDB2-4A44-A4D4-311E25BFD915

Q37203919-8F62E7BA-36E7-4E50-8C38-5BAD8EFD4E2F

Q37203919-B886C022-75D4-4353-8ACB-DC02A4B922A5

Q37203919-BF54765B-6015-4898-AC35-5E90014F3F63

P577

Q37203919-B367BE14-4E6C-49D6-84FF-D150472199F8

P698

Q37203919-7AC5184E-657F-4863-8779-F3C50C9B3F05

P932

Q37203919-A13204A2-14C8-47E1-9024-B651D4F1E223

P356

J.BJHH.2016.04.010

P1433

Revista brasileira de hematologia e hemoterapia

P1476

Age-adjusted international pro ...... non-Hodgkin lymphoma patients.

@en

P2093

Anna Fedina

http://www.w3.org/2001/XMLSchema#string

Carlos Sergio Chiattone

http://www.w3.org/2001/XMLSchema#string

Carmino Antonio de Souza

http://www.w3.org/2001/XMLSchema#string

Eliana Cristina Martins Miranda

http://www.w3.org/2001/XMLSchema#string

Katia Borgia Barbosa Pagnano

http://www.w3.org/2001/XMLSchema#string

Marcia Torresan Delamain

http://www.w3.org/2001/XMLSchema#string

Maria Gomes da Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Report of the Committee on Hodgkin's Disease Staging Classification

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Primary non-hodgkin lymphoma of the stomach: clinicopathological characteristics and prognostic factors in Iranian patients

Primary diffuse large B-cell lymphoma of the stomach.

Analysis of clinical characteristics, diagnosis, treatment and prognosis of 46 patients with primary gastrointestinal non-Hodgkin lymphoma.

Survival of patients with gastric lymphoma in Germany and in the United States.

Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan.

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.

P304

247-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BJHH.2016.04.010

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Merli

Stefano Luminari

Massimo Federico

Joana M. Desterro

P577

2016-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27521863

http://www.w3.org/2001/XMLSchema#string

P932

4997895

http://www.w3.org/2001/XMLSchema#string